Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnet
β¦ LIBER β¦
Detection and treatment of minimal residual disease in high-risk neuroblastoma
β Scribed by C. Patrick Reynolds
- Book ID
- 110882795
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 178 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1397-3142
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
[Pediatric Cancer] Neuroblastoma Volume
β
Hayat, M.A.
π
Article
π
2011
π
Springer Netherlands
π
Dutch
β 301 KB
Detecting minimal residual disease in ne
β
Klaus Beiske; Peter F. Ambros; Susan A. Burchill; Irene Y. Cheung; Katrien Swert
π
Article
π
2005
π
Elsevier Science
π
English
β 299 KB
Outcome prediction by molecular detectio
β
Horibe, Keizo ;Fukuda, Minoru ;Miyajima, Yuji ;Matsumoto, Kimikazu ;Kondo, Masar
π
Article
π
2001
π
John Wiley and Sons
π
English
β 88 KB
π 2 views
Background. We have determined whether sequential molecular detection of minimal residual disease (MRD) in bone marrow (BM) could predict the outcome of patients with advanced neuroblastoma (NB). Procedure. Bone marrow samples from 19 patients over 12 months of age with stage 4 neuroblastoma were se
Risk-adapted treatment according to mini
β
Nicola GΓΆkbuget; Michael Kneba; Thorsten Raff; Monika Bruggemann; Urban Scheurin
π
Article
π
2002
π
Elsevier Science
π
English
β 485 KB
International Symposium on βDetection an
π
Article
π
1983
π
Elsevier Science
β 47 KB
Detection of Minimal Residual Disease in
β
Thomas J. Moss
π
Article
π
1994
π
Elsevier Science
π
English
β 809 KB